Nerve Monitoring System Market worth 1.45 Billion USD by 2022

By -

The Global Nerve Monitoring System Market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period.

(EMAILWIRE.COM, August 11, 2021 ) The global nerve monitoring system market has been segmented on the basis of product, technology, application, end user, and region. Based on product, the nerve stimulation electrodes and probes segment commanded the largest share of the global nerve monitoring system market in 2017.

This large market share is mainly attributed to factors such as increasing awareness of healthcare professionals about clinical benefits associated with nerve monitoring, increasing number of complex & critical surgeries worldwide, and ongoing technological advancements in the field of nerve stimulation & monitoring.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155669000

The global nerve monitoring systems market is estimated to reach USD 1.45 billion by 2022; growing at a CAGR of 4.9% during the forecast period. The expansion in target patient population, growing availability of medical reimbursement for nerve monitoring procedures, and rising demand for surgical intervention among trauma cases across the globe are some key factors propelling the growth of nerve monitoring systems industry.

In 2016, North America held the largest share of the market and registers the highest growth rate during the forecast period. The growth of this North America market is attributed to the significant adoption of nerve monitoring owing to the growing number of clinical trials that have proved its therapeutic efficacy in surgeries and the availability of medical reimbursement in the US. Furthermore, the market growth is attributed to large patient population for target diseases, strong presence of device manufacturers in the region, and the availability of significant R&D investments to support nerve monitoring product development.

In 2016, Medtronic (Ireland) held the leading position in the market. Over the past three years, the company has focused on the R&D activities for the product innovation and increased its R&D expenditure for further growth in the industry. NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia), were few other key players operating in the market.

Target Audience:

# Nerve monitoring product manufacturers
# Nerve monitoring product suppliers and distributors
# Contract manufacturers
# Healthcare service providers [including hospitals, surgical centers, and ambulatory surgical centers (ASCs)]
# Research laboratories and academic institutes
# Clinical research organizations (CROs)
# Government regulatory authorities
# Independent associations and non-government organizations
# National and international regulatory authorities
# Market research firms

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=155669000

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Media Contact

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more